APA
Penka M., Schwarz J., Pavlík T., Pytiĺk R., Doubek M., Dulícek P., Kissová J., Hlusi A., Schutzová M., Cerná O., Brychtová Y., Szotkowski T., Volková Z., Seghetová J., Vozobulová V., Hadacová I., Hochová I., Voglová J. & Dusek L. (20081002). [What is the current treatment of patients with essential thrombocytopenia and other myeloproliferations accompanied with thrombocythemia [corrected] and what can be the predictive sign of the risk of thrombosis in such patients--a report from the registry of patients treated by Thromboreductine]. : Vnitrni lekarstvi.
Chicago
Penka M, Schwarz J, Pavlík T, Pytiĺk R, Doubek M, Dulícek P, Kissová J, Hlusi A, Schutzová M, Cerná O, Brychtová Y, Szotkowski T, Volková Z, Seghetová J, Vozobulová V, Hadacová I, Hochová I, Voglová J and Dusek L. 20081002. [What is the current treatment of patients with essential thrombocytopenia and other myeloproliferations accompanied with thrombocythemia [corrected] and what can be the predictive sign of the risk of thrombosis in such patients--a report from the registry of patients treated by Thromboreductine]. : Vnitrni lekarstvi.
Harvard
Penka M., Schwarz J., Pavlík T., Pytiĺk R., Doubek M., Dulícek P., Kissová J., Hlusi A., Schutzová M., Cerná O., Brychtová Y., Szotkowski T., Volková Z., Seghetová J., Vozobulová V., Hadacová I., Hochová I., Voglová J. and Dusek L. (20081002). [What is the current treatment of patients with essential thrombocytopenia and other myeloproliferations accompanied with thrombocythemia [corrected] and what can be the predictive sign of the risk of thrombosis in such patients--a report from the registry of patients treated by Thromboreductine]. : Vnitrni lekarstvi.
MLA
Penka M, Schwarz J, Pavlík T, Pytiĺk R, Doubek M, Dulícek P, Kissová J, Hlusi A, Schutzová M, Cerná O, Brychtová Y, Szotkowski T, Volková Z, Seghetová J, Vozobulová V, Hadacová I, Hochová I, Voglová J and Dusek L. [What is the current treatment of patients with essential thrombocytopenia and other myeloproliferations accompanied with thrombocythemia [corrected] and what can be the predictive sign of the risk of thrombosis in such patients--a report from the registry of patients treated by Thromboreductine]. : Vnitrni lekarstvi. 20081002.